VALDINIO CAMBRY: Open Payments
NPI 1891453072 · BOYNTON BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 52 payments from 15 companies in 2025. Trend: 2023 $632 · 2024 $1,188 · 2025 $1,666
Food & beverage: $1,565Education: $101
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 27 | $526 |
| Teva Pharmaceuticals USA, Inc. | 2 | $216 |
| E.R. Squibb & Sons, L.L.C. | 4 | $203 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Alkermes, Inc. | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $90 |
| ABBVIE INC. | 2 | $60 |
| Exact Sciences Corporation | 2 | $48 |
| ViiV Healthcare Company | 2 | $40 |
Products named: INGREZZA, COBENFY, FANAPT, LYBALVI, REXULTI, AUSTEDO XR, CAPLYTA, VRAYLAR.
Industry payments across FL — which companies pay providers there.
